These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H. Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669 [Abstract] [Full Text] [Related]
3. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Novakovic S, Hocevar M, Zgajnar J, Besic N, Stegel V. Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933 [Abstract] [Full Text] [Related]
4. Telomerase in (pre)neoplastic cervical disease. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries EG, Keith WN, van der Zee AG. Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123 [Abstract] [Full Text] [Related]
5. Quantification of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) mRNA in testicular tissue of infertile patients. Schrader M, Müller M, Heicappell R, Straub B, Miller K. Asian J Androl; 2001 Dec; 3(4):263-70. PubMed ID: 11753470 [Abstract] [Full Text] [Related]
6. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hayashidani Y, Hiyama E, Murakami Y, Sueda T. Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061 [Abstract] [Full Text] [Related]
7. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]. Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R. Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058 [Abstract] [Full Text] [Related]
8. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Ohuchida K, Mizumoto K, Ogura Y, Ishikawa N, Nagai E, Yamaguchi K, Tanaka M. Clin Cancer Res; 2005 Mar 15; 11(6):2285-92. PubMed ID: 15788678 [Abstract] [Full Text] [Related]
9. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W. J Pathol; 2002 Oct 15; 198(2):181-9. PubMed ID: 12237877 [Abstract] [Full Text] [Related]
10. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J. J Pathol; 2001 Jan 15; 193(1):21-6. PubMed ID: 11169511 [Abstract] [Full Text] [Related]
11. Expression of telomerase genes in thyroid carcinoma. Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Köhrle J, Rath FW, Dralle H. Int J Oncol; 2002 Aug 15; 21(2):265-72. PubMed ID: 12118320 [Abstract] [Full Text] [Related]
12. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH. Acta Otolaryngol; 2005 Apr 15; 125(4):409-14. PubMed ID: 15823813 [Abstract] [Full Text] [Related]
13. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR. Cancer; 2002 Nov 15; 95(10):2103-11. PubMed ID: 12412163 [Abstract] [Full Text] [Related]
14. Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer. Chen W, Xiong X, Zhou H, Zhou Q. Chin Med J (Engl); 2002 Feb 15; 115(2):290-2. PubMed ID: 11940351 [Abstract] [Full Text] [Related]
15. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Eur J Surg Oncol; 2002 Apr 15; 28(3):225-34. PubMed ID: 11944954 [Abstract] [Full Text] [Related]
16. hTERT expression in sporadic renal cell carcinomas. Paradis V, Bièche I, Dargère D, Bonvoust F, Ferlicot S, Olivi M, Lagha NB, Blanchet P, Benoît G, Vidaud M, Bedossa P. J Pathol; 2001 Sep 15; 195(2):209-17. PubMed ID: 11592100 [Abstract] [Full Text] [Related]
17. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M, Inoue M. Clin Cancer Res; 1998 Nov 15; 4(11):2807-10. PubMed ID: 9829746 [Abstract] [Full Text] [Related]
18. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Bièche I, Noguès C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M. Clin Cancer Res; 2000 Feb 15; 6(2):452-9. PubMed ID: 10690523 [Abstract] [Full Text] [Related]
19. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Widschwendter A, Müller HM, Hubalek MM, Wiedemair A, Fiegl H, Goebel G, Mueller-Holzner E, Marth C, Widschwendter M. Gynecol Oncol; 2004 May 15; 93(2):407-16. PubMed ID: 15099954 [Abstract] [Full Text] [Related]
20. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM. Anticancer Res; 2009 Apr 15; 29(4):1157-62. PubMed ID: 19414359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]